Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The record’s last-submitted and last-posted dates changed to November 10 and November 13, 2026, replacing the October dates.
    Difference
    0.0%
    Check dated 2026-11-14T13:25:09.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the pembrolizumab study in resectable or unresectable desmoplastic melanoma is displayed, with details on the study design, eligibility, outcomes, locations, and publications.
    Difference
    100%
    Check dated 2026-11-07T12:35:55.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, indicating a site software version update.
    Difference
    0.2%
    Check dated 2026-10-31T13:18:26.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    A site-wide notice announces NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial study record remains inaccessible.
    Difference
    1%
    Check dated 2026-10-24T14:58:15.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The footer's site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T14:47:32.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The site footer’s revision label changes from v3.7.0 to v3.7.1; the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T15:43:11.000Z thumbnail image

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.